Fundamental Analysis of Akoya Biosciences Inc - Growth / Value Index


AKYA - Valuation Highlights

Valuation Analysis

   Tsr Value Index - Very Poor Score of 12.50
   Price to Book Ratio of 443.33 suggesting that it is very expensive
   Book Value in last 3 years is trending down
Valuation Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Price to Earning -1028.39 -1773.75 -116372.25 %
Price to Book 450.24 2355.19 128149 % 4.28
Price to Sales 747.39 1386.07 96350.32 %
Enterprise Value to EBITDA Multiple -2.27 -2328.00 -136472.32 %


AKYA - Profitability Highlights

Profitability Analysis

   Company's Net Profit is increasing for last 5 Quarters
   Company's Profit Before Tax is increasing for last 5 Quarters
   Steady Growth in EPS for last four quarters
   Tsr Profitability Index - Very Poor Score of 5.00
   Very Low Dividend Yield of 0 %
   Negative Net profit for last two years
   Company Net profit is Negative for last 5 Quarters
   In the last three years, the company has given poor Net Margin
   In the last three years, the company has given poor Returns on Equity
   In the last three years, the company has given poor Returns on Assets
   Negative Net Margin MRQ
Profitability Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Return On Equity -129.54 -132.78 -10.11 % -71.77
Return On Asset -39.74 -39.58 1.36 % -15.18
Net Profit Margin -72.68 -78.14 17.19 % -127.98
Operating Profit Margin -61.20 -70.38 20.30 % -92.85
EBITDA Margin -64.26 -59.54 24.22 % -81.67


Highlights
Market Cap140750 K
Enterprise Value136327 K
Price/Book TTM450.24
Outstanding Share49386.20 K
Float/ Outstanding Share35.70%
Dividend Yield0 %
Share Holding
Guru Numbers
Price/Graham No0
Peter Lynch Ratio0
Piotroski F Score3.00
Altman Z Score-1.19
Sloan Ratio-0.089
Peter Lynch Fair Value0


AKYA - Growth Highlights

Growth Analysis

   Short term positive trend in total sale and net profit
   Tremendous increasing trend in total sale last 3 year
   Quarterly sales in last 5 years is trending up
   Tsr Growth Index - Very Poor Score of 16.40
   Operating Cash Flow decreasing for last 3 year
Growth Key Fields
Field TTM YoY Growth QoQ Growth
Revenue 93573.00 K 22.05 % 30.72 %
Gross Profit 52391.00 K 19.22 % 49.58 %
EBITDA -60130.00 K 7.51 % 33.82 %
Net Profit -68005.00 K 1.07 % 117.40 %
EPS -0.0028 99.91 % NA


AKYA - Stability Highlights

Stability Analysis

   Tsr Stability Index - Very Poor Score of 12.50
   Altman Z Score of -1.18 suggest high risk
   Company is unable to generate enough free cash to support the business.
   Interest Coverage of -7.59
Stability Key Ratios
Ratio Latest FY Yoy Change MRQ
Debt to Equity Ratio 1.46 28.16 % 2.41
Cash Ratio 2.35 7.30 %
Quick Ratio 2.94 11.49 % 2.38
Shareholders Equity 29.81 -10.42 %
Debt to EBITDA -1.45 -27.19 %


Historical Valuation Ratios of Akoya Biosciences Inc

Historical Valuation Ratios
Loading ...

Historical Profitability Ratios of Akoya Biosciences Inc

Historical Profitability Ratios
Loading ...

Historical Efficiency Ratios of Akoya Biosciences Inc

Historical Efficiency Ratios
Loading ...

Historical Solvency Ratios of Akoya Biosciences Inc

Historical Solvency Ratios
Loading ...


Note : All Data Generated at the End of Trading Hours (EOD Data)